Company / Free Cash Flow
Collegium Pharmaceutical, Inc. Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$327.6M
FY2025
5-year range
$101.6M / $327.6M
FY2021-FY2025
Trend
+61.1%
vs FY2024
Sector context
#28 of 195
Health Care
What the data says
Collegium Pharmaceutical, Inc.'s free cash flow of $328M is higher than 86% of companies in the Health Care sector (FY2025). Free Cash Flow has fluctuated over the past 10 years, ranging from -$76M in FY2016 to $328M in FY2025.
Based on SEC 10-K filings.
$328M in FY2025 with a 5-year CAGR of +30.0%. Top quartile in the Health Care sector.
Improved from $274M to $328M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- +38.8%
- 5-Year CAGR
- +30.0%
- 10-Year CAGR
- -
Sector benchmark
-29.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +30.0%, indicating consistent growth.
- In FY2025, free cash flow increased 61.1% year-over-year.
- Ranks #28 out of 195 companies in the Health Care sector.
- Lowest free cash flow in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $327.6M | +61.1% |
| FY2024 | $203.3M | -25.9% |
| FY2023 | $274.3M | +123.7% |
| FY2022 | $122.6M | +20.7% |
| FY2021 | $101.6M | +15.0% |
| FY2020 | $88.4M | +314.1% |
| FY2019 | $21.3M | -87.0% |
| FY2018 | $163.9M | +847.5% |
| FY2017 | -$21.9M | +71.0% |
| FY2016 | -$75.5M | -244.4% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026